Cargando…

The Impact of Telemedicine Visits on the Controlling High Blood Pressure Quality Measure During the COVID-19 Pandemic: Retrospective Cohort Study

BACKGROUND: Telemedicine visit use vastly expanded during the COVID-19 pandemic, and this has had an uncertain impact on cardiovascular care quality. OBJECTIVE: We sought to examine the association between telemedicine visits and the failure to meet the Controlling High Blood Pressure (BP) quality m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Siqin, Anstey, D Edmund, Grauer, Anne, Metser, Gil, Moise, Nathalie, Schwartz, Joseph, Kronish, Ian, Abdalla, Marwah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945081/
https://www.ncbi.nlm.nih.gov/pubmed/35138254
http://dx.doi.org/10.2196/32403
_version_ 1784673867368759296
author Ye, Siqin
Anstey, D Edmund
Grauer, Anne
Metser, Gil
Moise, Nathalie
Schwartz, Joseph
Kronish, Ian
Abdalla, Marwah
author_facet Ye, Siqin
Anstey, D Edmund
Grauer, Anne
Metser, Gil
Moise, Nathalie
Schwartz, Joseph
Kronish, Ian
Abdalla, Marwah
author_sort Ye, Siqin
collection PubMed
description BACKGROUND: Telemedicine visit use vastly expanded during the COVID-19 pandemic, and this has had an uncertain impact on cardiovascular care quality. OBJECTIVE: We sought to examine the association between telemedicine visits and the failure to meet the Controlling High Blood Pressure (BP) quality measure from the Centers for Medicare & Medicaid Services. METHODS: This was a retrospective cohort study of 32,727 adult patients with hypertension who were seen in primary care and cardiology clinics at an urban, academic medical center from February to December 2020. The primary outcome was a failure to meet the Controlling High Blood Pressure quality measure, which was defined as having no BP recorded or having a last recorded BP of ≥140/90 mm Hg (ie, poor BP control). Multivariable logistic regression was used to assess the association between telemedicine visit use during the study period (none, 1 telemedicine visit, or ≥2 telemedicine visits) and poor BP control; we adjusted for demographic and clinical characteristics. RESULTS: During the study period, no BP was recorded for 2.3% (486/20,745) of patients with in-person visits only, 27.1% (1863/6878) of patients with 1 telemedicine visit, and 25% (1277/5104) of patients with ≥2 telemedicine visits. After adjustment, telemedicine use was associated with poor BP control (1 telemedicine visit: odds ratio [OR] 2.06, 95% CI 1.94-2.18; P<.001; ≥2 telemedicine visits: OR 2.49, 95% CI 2.31-2.68; P<.001; reference: in-person visits only). This effect disappeared when the analysis was restricted to patients with at least 1 recorded BP (1 telemedicine visit: OR 0.89, 95% CI 0.83-0.95; P=.001; ≥2 telemedicine visits: OR 0.91, 95% CI 0.83-0.99; P=.03). CONCLUSIONS: Increased telemedicine visit use is associated with poorer performance on the Controlling High Blood Pressure quality measure. However, telemedicine visit use may not negatively impact BP control when BP is recorded.
format Online
Article
Text
id pubmed-8945081
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-89450812022-03-25 The Impact of Telemedicine Visits on the Controlling High Blood Pressure Quality Measure During the COVID-19 Pandemic: Retrospective Cohort Study Ye, Siqin Anstey, D Edmund Grauer, Anne Metser, Gil Moise, Nathalie Schwartz, Joseph Kronish, Ian Abdalla, Marwah JMIR Form Res Original Paper BACKGROUND: Telemedicine visit use vastly expanded during the COVID-19 pandemic, and this has had an uncertain impact on cardiovascular care quality. OBJECTIVE: We sought to examine the association between telemedicine visits and the failure to meet the Controlling High Blood Pressure (BP) quality measure from the Centers for Medicare & Medicaid Services. METHODS: This was a retrospective cohort study of 32,727 adult patients with hypertension who were seen in primary care and cardiology clinics at an urban, academic medical center from February to December 2020. The primary outcome was a failure to meet the Controlling High Blood Pressure quality measure, which was defined as having no BP recorded or having a last recorded BP of ≥140/90 mm Hg (ie, poor BP control). Multivariable logistic regression was used to assess the association between telemedicine visit use during the study period (none, 1 telemedicine visit, or ≥2 telemedicine visits) and poor BP control; we adjusted for demographic and clinical characteristics. RESULTS: During the study period, no BP was recorded for 2.3% (486/20,745) of patients with in-person visits only, 27.1% (1863/6878) of patients with 1 telemedicine visit, and 25% (1277/5104) of patients with ≥2 telemedicine visits. After adjustment, telemedicine use was associated with poor BP control (1 telemedicine visit: odds ratio [OR] 2.06, 95% CI 1.94-2.18; P<.001; ≥2 telemedicine visits: OR 2.49, 95% CI 2.31-2.68; P<.001; reference: in-person visits only). This effect disappeared when the analysis was restricted to patients with at least 1 recorded BP (1 telemedicine visit: OR 0.89, 95% CI 0.83-0.95; P=.001; ≥2 telemedicine visits: OR 0.91, 95% CI 0.83-0.99; P=.03). CONCLUSIONS: Increased telemedicine visit use is associated with poorer performance on the Controlling High Blood Pressure quality measure. However, telemedicine visit use may not negatively impact BP control when BP is recorded. JMIR Publications 2022-03-23 /pmc/articles/PMC8945081/ /pubmed/35138254 http://dx.doi.org/10.2196/32403 Text en ©Siqin Ye, D Edmund Anstey, Anne Grauer, Gil Metser, Nathalie Moise, Joseph Schwartz, Ian Kronish, Marwah Abdalla. Originally published in JMIR Formative Research (https://formative.jmir.org), 23.03.2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on https://formative.jmir.org, as well as this copyright and license information must be included.
spellingShingle Original Paper
Ye, Siqin
Anstey, D Edmund
Grauer, Anne
Metser, Gil
Moise, Nathalie
Schwartz, Joseph
Kronish, Ian
Abdalla, Marwah
The Impact of Telemedicine Visits on the Controlling High Blood Pressure Quality Measure During the COVID-19 Pandemic: Retrospective Cohort Study
title The Impact of Telemedicine Visits on the Controlling High Blood Pressure Quality Measure During the COVID-19 Pandemic: Retrospective Cohort Study
title_full The Impact of Telemedicine Visits on the Controlling High Blood Pressure Quality Measure During the COVID-19 Pandemic: Retrospective Cohort Study
title_fullStr The Impact of Telemedicine Visits on the Controlling High Blood Pressure Quality Measure During the COVID-19 Pandemic: Retrospective Cohort Study
title_full_unstemmed The Impact of Telemedicine Visits on the Controlling High Blood Pressure Quality Measure During the COVID-19 Pandemic: Retrospective Cohort Study
title_short The Impact of Telemedicine Visits on the Controlling High Blood Pressure Quality Measure During the COVID-19 Pandemic: Retrospective Cohort Study
title_sort impact of telemedicine visits on the controlling high blood pressure quality measure during the covid-19 pandemic: retrospective cohort study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945081/
https://www.ncbi.nlm.nih.gov/pubmed/35138254
http://dx.doi.org/10.2196/32403
work_keys_str_mv AT yesiqin theimpactoftelemedicinevisitsonthecontrollinghighbloodpressurequalitymeasureduringthecovid19pandemicretrospectivecohortstudy
AT ansteydedmund theimpactoftelemedicinevisitsonthecontrollinghighbloodpressurequalitymeasureduringthecovid19pandemicretrospectivecohortstudy
AT graueranne theimpactoftelemedicinevisitsonthecontrollinghighbloodpressurequalitymeasureduringthecovid19pandemicretrospectivecohortstudy
AT metsergil theimpactoftelemedicinevisitsonthecontrollinghighbloodpressurequalitymeasureduringthecovid19pandemicretrospectivecohortstudy
AT moisenathalie theimpactoftelemedicinevisitsonthecontrollinghighbloodpressurequalitymeasureduringthecovid19pandemicretrospectivecohortstudy
AT schwartzjoseph theimpactoftelemedicinevisitsonthecontrollinghighbloodpressurequalitymeasureduringthecovid19pandemicretrospectivecohortstudy
AT kronishian theimpactoftelemedicinevisitsonthecontrollinghighbloodpressurequalitymeasureduringthecovid19pandemicretrospectivecohortstudy
AT abdallamarwah theimpactoftelemedicinevisitsonthecontrollinghighbloodpressurequalitymeasureduringthecovid19pandemicretrospectivecohortstudy
AT yesiqin impactoftelemedicinevisitsonthecontrollinghighbloodpressurequalitymeasureduringthecovid19pandemicretrospectivecohortstudy
AT ansteydedmund impactoftelemedicinevisitsonthecontrollinghighbloodpressurequalitymeasureduringthecovid19pandemicretrospectivecohortstudy
AT graueranne impactoftelemedicinevisitsonthecontrollinghighbloodpressurequalitymeasureduringthecovid19pandemicretrospectivecohortstudy
AT metsergil impactoftelemedicinevisitsonthecontrollinghighbloodpressurequalitymeasureduringthecovid19pandemicretrospectivecohortstudy
AT moisenathalie impactoftelemedicinevisitsonthecontrollinghighbloodpressurequalitymeasureduringthecovid19pandemicretrospectivecohortstudy
AT schwartzjoseph impactoftelemedicinevisitsonthecontrollinghighbloodpressurequalitymeasureduringthecovid19pandemicretrospectivecohortstudy
AT kronishian impactoftelemedicinevisitsonthecontrollinghighbloodpressurequalitymeasureduringthecovid19pandemicretrospectivecohortstudy
AT abdallamarwah impactoftelemedicinevisitsonthecontrollinghighbloodpressurequalitymeasureduringthecovid19pandemicretrospectivecohortstudy